Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation

Free Radical Biology and Medicine

Volumn 65, Issue , 2013, Pages 789-799

  Hyeon, Seungha ^a   Lee, Hyojung ^a   Yang, Yoohee ^a   Jeong, Woojin ^a  

^a Ewha Womans University   (South Korea)

Author keywords

Free radicals; Mitogen activated protein kinases; Nrf2; OC differentiation; Reactive oxygen species; Redox regulation

Indexed keywords

CURCUMIN; DIPHENYLIODONIUM SALT; GLUTATHIONE; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN C FOS; STRESS ACTIVATED PROTEIN KINASE; SULFORAPHANE; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NRF2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NFATC1 PROTEIN, MOUSE; NFE2L2 PROTEIN, MOUSE; PEROXIDASE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; CONTROLLED STUDY; ENHANCER REGION; ENVIRONMENTAL STRESS; GENE EXPRESSION; HUMAN; MALE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; ANIMAL; C57BL MOUSE; CELL DIFFERENTIATION; DEFICIENCY; ENZYME ACTIVATION; GENETICS; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

MUS;

ANIMALS; BONE RESORPTION; CELL DIFFERENTIATION; ENZYME ACTIVATION; GLUTATHIONE; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-E2-RELATED FACTOR 2; NF-KAPPA B; NFATC TRANSCRIPTION FACTORS; OSTEOCLASTS; OXIDATIVE STRESS; PEROXIDASES; PROTO-ONCOGENE PROTEINS C-FOS; RANK LIGAND; REACTIVE OXYGEN SPECIES;

EID: 84883641346     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2013.08.005     Document Type: Article

References (59)

1. M. Zaidi Skeletal remodeling in health and disease Nat. Med 13 2007 791 801 (Pubitemid 47038187)
2. G.R. Mundy Osteoporosis and inflammation Nutr. Rev. 65 2007 S147 151
3. K. Aoki, H. Saito, C. Itzstein, M. Ishiguro, T. Shibata, R. Blanque, A.H. Mian, M. Takahashi, Y. Suzuki, M. Yoshimatsu, A. Yamaguchi, P. Deprez, P. Mollat, R. Murali, K. Ohya, W.C. Horne, and R. Baron A TNF receptor loop peptide mimic blocks RANK ligand-induced signaling, bone resorption, and bone loss J. Clin. Invest. 116 2006 1525 1534
4. F.P. Ross, and S. Teitelbaum L. alphavbeta3 and macrophage colony-stimulating factor: partners in osteoclast biology Immunol. Rev. 208 2005 88 105 (Pubitemid 41746387)
5. D.M. Anderson, E. Maraskovsky, W.L. Billingsley, W.C. Dougall, M.E. Tometsko, E.R. Roux, M.C. Teepe, R.F. DuBose, D. Cosman, and L. Galibert A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function Nature 390 1997 175 179 (Pubitemid 27507987)
6. B.R. Wong, J. Rho, J. Arron, E. Robinson, J. Orlinick, M. Chao, S. Kalachikov, E. Cayani, F.S. Bartlett 3rd, W.N. Frankel, S.Y. Lee, and Y. Choi TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells J. Biol. Chem. 272 1997 25190 25194 (Pubitemid 27415705)
7. H. Yasuda, N. Shima, N. Nakagawa, K. Yamaguchi, M. Kinosaki, S. Mochizuki, A. Tomoyasu, K. Yano, M. Goto, A. Murakami, E. Tsuda, T. Morinaga, K. Higashio, N. Udagawa, N. Takahashi, and T. Suda Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL Proc. Natl. Acad. Sci. USA 95 1998 3597 3602
8. D.L. Lacey, E. Timms, H.L. Tan, M.J. Kelley, C.R. Dunstan, T. Burgess, R. Elliott, A. Colombero, G. Elliott, S. Scully, H. Hsu, J. Sullivan, N. Hawkins, E. Davy, C. Capparelli, A. Eli, Y.X. Qian, S. Kaufman, I. Sarosi, V. Shalhoub, G. Senaldi, J. Guo, J. Delaney, and W.J. Boyle Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation Cell 93 1998 165 176 (Pubitemid 28180851)
9. G.A. Rodan, and T.J. Martin Therapeutic approaches to bone diseases Science 289 2000 1508 1514
10. L.E. Theill, W.J. Boyle, and J.M. Penninger RANK-L and RANK: T cells, bone loss, and mammalian evolution Annu. Rev. Immunol. 20 2002 795 823 (Pubitemid 34293440)
11. M. Asagiri, and H. Takayanagi The molecular understanding of osteoclast differentiation Bone 40 2007 251 264 (Pubitemid 46054562)
12. H. Takayanagi Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems Nat. Rev. Immunol. 7 2007 292 304 (Pubitemid 46480961)
13. E.F. Wagner, and R. Eferl Fos/AP-1 proteins in bone and the immune system Immunol. Rev. 208 2005 126 140 (Pubitemid 41746389)
14. I.R. Garrett, B.F. Boyce, R.O. Oreffo, L. Bonewald, J. Poser, and G.R. Mundy Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo J. Clin. Invest. 85 1990 632 639 (Pubitemid 20087462)
15. B.E. Bax, A.S. Alam, B. Banerji, C.M. Bax, P.J. Bevis, C.R. Stevens, B.S. Moonga, D.R. Blake, and M. Zaidi Stimulation of osteoclastic bone resorption by hydrogen peroxide Biochem. Biophys. Res. Commun. 183 1992 1153 1158
16. J.M. Lean, C.J. Jagger, B. Kirstein, K. Fuller, and T.J. Chambers Hydrogen peroxide is essential for estrogen-deficiency bone loss and osteoclast formation Endocrinology 146 2005 728 735 (Pubitemid 40129828)
17. A.G. Darden, W.L. Ries, W.C. Wolf, R.M. Rodriguiz, and L.L. Key Jr. Osteoclastic superoxide production and bone resorption: stimulation and inhibition by modulators of NADPH oxidase J. Bone Miner. Res. 11 1996 671 675 (Pubitemid 26123918)
18. M.J. Steinbeck, W.H. Appel Jr, A.J. Verhoeven, and M.J. Karnovsky NADPH-oxidase expression and in situ production of superoxide by osteoclasts actively resorbing bone J. Cell Biol. 126 1994 765 772 (Pubitemid 24241388)
19. N.K. Lee, Y.G. Choi, J.Y. Baik, S.Y. Han, D.W. Jeong, Y.S. Bae, N. Kim, and S.Y. Lee A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation Blood 106 2005 852 859 (Pubitemid 41076424)
20. J.M. Lean, J.T. Davies, K. Fuller, C.J. Jagger, B. Kirstein, G.A. Partington, Z.L. Urry, and T.J. Chambers A crucial role for thiol antioxidants in estrogen-deficiency bone loss J. Clin. Invest. 112 2003 915 923 (Pubitemid 38063749)
21. L.G. Rao, N. Krishnadev, K. Banasikowska, A.V. Rao, and I Lycopene - effect on osteoclasts: lycopene inhibits basal and parathyroid hormone-stimulated osteoclast formation and mineral resorption mediated by reactive oxygen species in rat bone marrow cultures J. Med. Food 6 2003 69 78 (Pubitemid 37128466)
22. H.J. Kim, E.J. Chang, H.M. Kim, S.B. Lee, H.D. Kim, G. Su Kim, and H.H. Kim Antioxidant α-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-κB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-κB ligand and tumor necrosis factor-α Free Radic. Biol. Med 40 2006 1483 1493
23. J.R. Chen, O.P. Lazarenko, K. Shankar, M.L. Blackburn, C.K. Lumpkin, T.M. Badger, and M.J. Ronis Inhibition of NADPH oxidases prevents chronic ethanol-induced bone loss in female rats J. Pharmacol. Exp. Ther. 336 2011 734 742
24. H.J. Moon, W.K. Ko, S.W. Han, D.S. Kim, Y.S. Hwang, H.K. Park, and I.K. Kwon Antioxidants, like coenzyme Q10, selenite, and curcumin, inhibited osteoclast differentiation by suppressing reactive oxygen species generation Biochem. Biophys. Res. Commun. 418 2012 247 253
25. K. Itoh, T. Chiba, S. Takahashi, T. Ishii, K. Igarashi, Y. Katoh, T. Oyake, N. Hayashi, K. Satoh, I. Hatayama, M. Yamamoto, and Y. Nabeshima An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements Biochem. Biophys. Res. Commun. 236 1997 313 322 (Pubitemid 27373291)
26. T. Ishii, K. Itoh, S. Takahashi, H. Sato, T. Yanagawa, Y. Katoh, S. Bannai, and M. Yamamoto Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages J. Biol. Chem. 275 2000 16023 16029 (Pubitemid 30366908)
27. H. Motohashi, and M. Yamamoto Nrf2-Keap1 defines a physiologically important stress response mechanism Trends Mol. Med. 10 2004 549 557 (Pubitemid 39433824)
28. H.Y. Cho, S.P. Reddy, and S.R. Kleeberger Nrf2 defends the lung from oxidative stress Antioxid. Redox Signaling 8 2006 76 87 (Pubitemid 43324533)
29. K. Itoh, N. Wakabayashi, Y. Katoh, T. Ishii, K. Igarashi, J.D. Engel, and M. Yamamoto Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain Genes Dev. 13 1999 76 86 (Pubitemid 29045117)
30. A.T. Dinkova-Kostova, W.D. Holtzclaw, R.N. Cole, K. Itoh, N. Wakabayashi, Y. Katoh, M. Yamamoto, and P. Talalay Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants Proc. Natl. Acad. Sci. USA 99 2002 11908 11913 (Pubitemid 34994497)
31. R.K. Thimmulappa, K.H. Mai, S. Srisuma, T.W. Kensler, M. Yamamoto, and S. Biswal Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray Cancer Res. 62 2002 5196 5203 (Pubitemid 35033454)
32. Y.J. Surh Cancer chemoprevention with dietary phytochemicals Nat. Rev. Cancer 3 2003 768 780
33. M.K. Kwak, N. Wakabayashi, K. Itoh, H. Motohashi, M. Yamamoto, and T.W. Kensler Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway: identification of novel gene clusters for cell survival J. Biol. Chem. 278 2003 8135 8145 (Pubitemid 36800555)
34. T. Rangasamy, J. Guo, W.A. Mitzner, J. Roman, A. Singh, A.D. Fryer, M. Yamamoto, T.W. Kensler, R.M. Tuder, S.N. Georas, and S. Biswal Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice J. Exp. Med. 202 2005 47 59 (Pubitemid 41002909)
35. R. Hu, C. Xu, G. Shen, M.R. Jain, T.O. Khor, A. Gopalkrishnan, W. Lin, B. Reddy, J.Y. Chan, and A.N. Kong Gene expression profiles induced by cancer chemopreventive isothiocyanate sulforaphane in the liver of C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice Cancer Lett. 243 2006 170 192 (Pubitemid 44485856)
36. I. Chowdhury, Y. Mo, L. Gao, A. Kazi, A.B. Fisher, and S.I. Feinstein Oxidant stress stimulates expression of the human peroxiredoxin 6 gene by a transcriptional mechanism involving an antioxidant response element Free Radic. Biol. Med. 46 2009 146 153
37. J.D. Hayes, and M. McMahon NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer Trends Biochem. Sci. 34 2009 176 188
38. W. Jeong, S.H. Bae, M.B. Toledano, and S.G. Rhee Role of sulfiredoxin as a regulator of peroxiredoxin function and regulation of its expression Free Radic. Biol. Med. 53 2012 447 456
39. T.W. Kensler, N. Wakabayashi, and S. Biswal Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway Annu. Rev. Pharmacol. Toxicol. 47 2007 89 116
40. T.S. Chang, W. Jeong, H.A. Woo, S.M. Lee, S. Park, and S.G. Rhee Characterization of mammalian sulfiredoxin and its reactivation of hyperoxidized peroxiredoxin through reduction of cysteine sulfinic acid in the active site to cysteine J. Biol. Chem. 279 2004 50994 51001 (Pubitemid 40017840)
41. Y.S. Bae, S.W. Kang, M.S. Seo, I.C. Baines, E. Tekle, P.B. Chock, and S.G. Rhee Epidermal growth factor (EGF)-induced generation of hydrogen peroxide: role in EGF receptor-mediated tyrosine phosphorylation J. Biol. Chem. 272 1997 217 221 (Pubitemid 27021147)
42. S.L. Teitelbaum Bone resorption by osteoclasts Science 289 2000 1504 1508
43. M.S. Hayden, and S. Ghosh Signaling to NF-kappaB Genes Dev. 18 2004 2195 2224
44. Z.H. Lee, and H.H. Kim Signal transduction by receptor activator of nuclear factor κB in osteoclasts Biochem. Biophys. Res. Commun. 305 2003 211 214 (Pubitemid 36555454)
45. V. Iotsova, J. Caamano, J. Loy, Y. Yang, A. Lewin, and R. Bravo Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2 Nat. Med 3 1997 1285 1289 (Pubitemid 27508833)
46. M.G. Ruocco, S. Maeda, J.M. Park, T. Lawrence, L.C. Hsu, Y. Cao, G. Schett, E.F. Wagner, and M. Karin IκB kinase (IKK)β, but not IKKα, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss J. Exp. Med. 201 2005 1677 1687 (Pubitemid 40721011)
47. R.J. Davis Signal transduction by the JNK group of MAP kinases Cell 103 2000 239 252
48. S.R. Lee, K.S. Kwon, S.R. Kim, and S.G. Rhee Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor J. Biol. Chem. 273 1998 15366 15372 (Pubitemid 28298140)
49. T.C. Meng, T. Fukada, and N.K. Tonks Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo Mol. Cell 9 2002 387 399 (Pubitemid 34195563)
50. Z.Q. Wang, C. Ovitt, A.E. Grigoriadis, U. Mohle-Steinlein, U. Ruther, and E.F. Wagner Bone and haematopoietic defects in mice lacking c-fos Nature 360 1992 741 745 (Pubitemid 23012271)
51. K. Matsuo, D.L. Galson, C. Zhao, L. Peng, C. Laplace, K.Z. Wang, M.A. Bachler, H. Amano, H. Aburatani, H. Ishikawa, and E.F. Wagner Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos J. Biol. Chem. 279 2004 26475 26480 (Pubitemid 38798801)
52. 2 for platelet-derived growth factor signal transduction Science 270 1995 296 299
53. S.G. Rhee, S.W. Kang, W. Jeong, T.S. Chang, K.S. Yang, and H.A. Woo Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins Curr. Opin. Cell Biol. 17 2005 183 189 (Pubitemid 40380942)
54. M.H. Choi, I.K. Lee, G.W. Kim, B.U. Kim, Y.H. Han, D.Y. Yu, H.S. Park, K.Y. Kim, J.S. Lee, C. Choi, Y.S. Bae, B.I. Lee, S.G. Rhee, and S.W. Kang Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II Nature 435 2005 347 353 (Pubitemid 40745544)
55. S.W. Kang, S.G. Rhee, T.S. Chang, W. Jeong, and M.H. Choi 2-Cys peroxiredoxin function in intracellular signal transduction: therapeutic implications Trends Mol. Med. 11 2005 571 578 (Pubitemid 41713999)
56. D.H. Kang, D.J. Lee, K.W. Lee, Y.S. Park, J.Y. Lee, S.H. Lee, Y.J. Koh, G.Y. Koh, C. Choi, D.Y. Yu, J. Kim, and S.W. Kang Peroxiredoxin II is an essential antioxidant enzyme that prevents the oxidative inactivation of VEGF receptor-2 in vascular endothelial cells Mol. Cell 44 2011 545 558
57. T. Rana, M.A. Schultz, M.L. Freeman, and S. Biswas Loss of Nrf2 accelerates ionizing radiation-induced bone loss by upregulating RANKL Free Radic. Biol. Med. 53 2012 2298 2307
58. S.J. Kim, S.Y. Kang, H.H. Shin, and H.S. Choi Sulforaphane inhibits osteoclastogenesis by inhibiting nuclear factor-kappaB Mol. Cells 20 2005 364 370
59. A.C. Bharti, Y. Takada, and B.B. Aggarwal Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis J. Immunol 172 2004 5940 5947 (Pubitemid 38621193)